Abstract
PTH and strontium ranelate (SrR) have both been shown to reduce bone loss induced by immobilization. PTH is a potent bone anabolic agent, whereas SrR has been suggested to be an antiresorptive as well as a bone anabolic agent.The aim of the study was to investigate whether PTH, SrR, and PTH and SrR in combination could counteract immobilization-induced bone loss in a rat model.Immobilization was induced by injecting 4. IU Botox (BTX) into the muscles of the right hind limb. Seventy-two female Wistar rats, 3-months-old, were divided into the following groups: Baseline, Controls, BTX, BTX + PTH, BTX + SrR, and BTX + PTH + SrR (n = 12 in each group). PTH was given as injections (SC) at a dosage of 60 μg/kg/d, and SrR as 900. mg/kg/d in the diet. The experiment lasted for 4. weeks.BTX resulted in lower trabecular bone formation rate (-68%) and periosteal bone formation rate (-91%), and a higher fraction of osteoclast-covered surfaces (+ 53%) compared with controls. This was accompanied by significantly lower trabecular bone volume fraction (-24%), trabecular thickness (-16%), and bone strength (-14% to -32% depending on site). PTH alone counteracted immobilization-induced losses in trabecular (4-fold increase vs. BTX) and periosteal (5-fold increase vs. BTX) bone formation rate, trabecular thickness (+ 25% vs. BTX) and femoral neck strength (+ 24% vs. BTX). In contrast, SrR did not influence BTX-induced loss of bone formation rate, trabecular bone volume fraction, trabecular thickness, or bone strength. Finally, no additive effect was found when PTH and SrR treatments were combined.In conclusion, PTH counteracted loss in bone architecture and bone strength in immobilized rats, whereas as no effect of SrR was found. Moreover, no additional effect was found by combining PTH with SrR.
| Original language | English |
|---|---|
| Pages (from-to) | 51-58 |
| Number of pages | 8 |
| Journal | Bone |
| Volume | 53 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Mar 1 2013 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Endocrinology, Diabetes and Metabolism
- Physiology
- Histology
Cite this
}
PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats. / Brüel, Annemarie; Vegger, Jens Bay; Raffalt, Anders Christer; Andersen, Jens Enevold Thaulov; Thomsen, Jesper Skovhus.
In: Bone, Vol. 53, No. 1, 01.03.2013, p. 51-58.Research output: Contribution to journal › Article
TY - JOUR
T1 - PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats
AU - Brüel, Annemarie
AU - Vegger, Jens Bay
AU - Raffalt, Anders Christer
AU - Andersen, Jens Enevold Thaulov
AU - Thomsen, Jesper Skovhus
PY - 2013/3/1
Y1 - 2013/3/1
N2 - PTH and strontium ranelate (SrR) have both been shown to reduce bone loss induced by immobilization. PTH is a potent bone anabolic agent, whereas SrR has been suggested to be an antiresorptive as well as a bone anabolic agent.The aim of the study was to investigate whether PTH, SrR, and PTH and SrR in combination could counteract immobilization-induced bone loss in a rat model.Immobilization was induced by injecting 4. IU Botox (BTX) into the muscles of the right hind limb. Seventy-two female Wistar rats, 3-months-old, were divided into the following groups: Baseline, Controls, BTX, BTX + PTH, BTX + SrR, and BTX + PTH + SrR (n = 12 in each group). PTH was given as injections (SC) at a dosage of 60 μg/kg/d, and SrR as 900. mg/kg/d in the diet. The experiment lasted for 4. weeks.BTX resulted in lower trabecular bone formation rate (-68%) and periosteal bone formation rate (-91%), and a higher fraction of osteoclast-covered surfaces (+ 53%) compared with controls. This was accompanied by significantly lower trabecular bone volume fraction (-24%), trabecular thickness (-16%), and bone strength (-14% to -32% depending on site). PTH alone counteracted immobilization-induced losses in trabecular (4-fold increase vs. BTX) and periosteal (5-fold increase vs. BTX) bone formation rate, trabecular thickness (+ 25% vs. BTX) and femoral neck strength (+ 24% vs. BTX). In contrast, SrR did not influence BTX-induced loss of bone formation rate, trabecular bone volume fraction, trabecular thickness, or bone strength. Finally, no additive effect was found when PTH and SrR treatments were combined.In conclusion, PTH counteracted loss in bone architecture and bone strength in immobilized rats, whereas as no effect of SrR was found. Moreover, no additional effect was found by combining PTH with SrR.
AB - PTH and strontium ranelate (SrR) have both been shown to reduce bone loss induced by immobilization. PTH is a potent bone anabolic agent, whereas SrR has been suggested to be an antiresorptive as well as a bone anabolic agent.The aim of the study was to investigate whether PTH, SrR, and PTH and SrR in combination could counteract immobilization-induced bone loss in a rat model.Immobilization was induced by injecting 4. IU Botox (BTX) into the muscles of the right hind limb. Seventy-two female Wistar rats, 3-months-old, were divided into the following groups: Baseline, Controls, BTX, BTX + PTH, BTX + SrR, and BTX + PTH + SrR (n = 12 in each group). PTH was given as injections (SC) at a dosage of 60 μg/kg/d, and SrR as 900. mg/kg/d in the diet. The experiment lasted for 4. weeks.BTX resulted in lower trabecular bone formation rate (-68%) and periosteal bone formation rate (-91%), and a higher fraction of osteoclast-covered surfaces (+ 53%) compared with controls. This was accompanied by significantly lower trabecular bone volume fraction (-24%), trabecular thickness (-16%), and bone strength (-14% to -32% depending on site). PTH alone counteracted immobilization-induced losses in trabecular (4-fold increase vs. BTX) and periosteal (5-fold increase vs. BTX) bone formation rate, trabecular thickness (+ 25% vs. BTX) and femoral neck strength (+ 24% vs. BTX). In contrast, SrR did not influence BTX-induced loss of bone formation rate, trabecular bone volume fraction, trabecular thickness, or bone strength. Finally, no additive effect was found when PTH and SrR treatments were combined.In conclusion, PTH counteracted loss in bone architecture and bone strength in immobilized rats, whereas as no effect of SrR was found. Moreover, no additional effect was found by combining PTH with SrR.
UR - http://www.scopus.com/inward/record.url?scp=84871503533&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871503533&partnerID=8YFLogxK
U2 - 10.1016/j.bone.2012.11.037
DO - 10.1016/j.bone.2012.11.037
M3 - Article
C2 - 23246791
AN - SCOPUS:84871503533
VL - 53
SP - 51
EP - 58
JO - Bone
JF - Bone
SN - 8756-3282
IS - 1
ER -